Form 3 - Initial statement of beneficial ownership of securities
October 18 2023 - 5:16AM
Edgar (US Regulatory)
Exhibit 24
POWER OF ATTORNEY
Know all by these presents, that, for good and
valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the undersigned hereby constitutes and appoints
each of Mark Strobeck, Ph.D., Megan Timmins and Ryan Murr, and any of their substitutes, signing singly, the undersigned’s true
and lawful attorney-in-fact to:
(1) execute for and on behalf
of the undersigned (in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder
(the “Exchange Act”)), any and all Forms 3, 4 and/or 5, and any amendments thereto, that are necessary or advisable for
the undersigned to file under Section 16(a) (collectively, “Documents”) with respect to the undersigned’s
holdings of and transactions in the securities issued by Rockwell Medical, Inc., a Delaware corporation (the “Company”).
(2) do and perform any and all
acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Documents and timely file
such Documents with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
(3) take any other action of any
type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest
of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact’s discretion.
The undersigned hereby grants to each such attorney-in-fact
full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally
present, with full power of substitution or revocation, hereby ratifying and confirming all that each such attorney-in-fact (or such attorney-in-fact’s
substitute or substitutes) shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that each attorney-in-fact, in serving in such capacity at the request of the undersigned,
is not assuming, nor is such attorney-in-fact’s substitute or substitutes or the Company assuming, any of the undersigned’s
responsibilities to comply with the Exchange Act.
The undersigned agrees that such attorney-in-fact
may rely entirely on information furnished orally or in writing by the undersigned to such attorney-in-fact. The undersigned also agrees
to indemnify and hold harmless the Company and such attorney-in-fact against any losses, claims, damages or liabilities (or actions in
these respects) that arise out of or are based on any untrue statement or omission of necessary facts in the information provided by the
undersigned to such attorney-in-fact for purposes of executing, acknowledging, delivering and filing Documents and agrees to reimburse
the Company and such attorney-in-fact for any legal or other expenses reasonably incurred in connection with investigating or defending
against any such loss, claim, damage, liability or action.
This Power of Attorney shall remain in full force
and effect until the undersigned is no longer required to file Documents with respect to the undersigned’s holdings of and transactions
in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each of the foregoing
attorneys-in-fact.
IN
WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 1st day of October, 2023.
Rockwell Medical (NASDAQ:RMTI)
Historical Stock Chart
From Apr 2024 to May 2024
Rockwell Medical (NASDAQ:RMTI)
Historical Stock Chart
From May 2023 to May 2024